<?xml version='1.0' encoding='utf-8'?>
<document id="23973525"><sentence text="The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination."><entity charOffset="4-17" id="DDI-PubMed.23973525.s1.e0" text="anthraquinone" /></sentence><sentence text="Rhein, a major metabolite of the prodrug diacerein and a major component of the medicinal herb Rheum sp" /><sentence text=", is used for its beneficial effects in a variety of clinical applications including the treatment of osteoarthritis and diabetic nephropathy" /><sentence text=" The physicochemical properties of rhein are consistent with those of known organic anion transporter (OAT) substrates and inhibitors"><entity charOffset="35-40" id="DDI-PubMed.23973525.s4.e0" text="rhein" /></sentence><sentence text=" Therefore, the inhibitory effect of rhein on human (h) OAT1, hOAT3, hOAT4, and murine (m) Oat1 and mOat3 was examined in heterologous cell lines stably expressing each transporter in isolation"><entity charOffset="37-41" id="DDI-PubMed.23973525.s5.e0" text="rhein" /></sentence><sentence text=" Rhein was shown to potently inhibit hOAT1 and hOAT3, with IC50 estimates in the low nanomolar range (IC50=77" /><sentence text="1±5" /><sentence text="5 nM and 8" /><sentence text="4±2" /><sentence text="5 nM, respectively), while poor affinity was observed for hOAT4 (IC50&gt;100 μM)" /><sentence text=" Marked species differences were observed with hOAT1 and hOAT3 exhibiting 3- and 28-fold higher affinity for rhein as compared to their murine orthologs"><entity charOffset="109-114" id="DDI-PubMed.23973525.s11.e0" text="rhein" /></sentence><sentence text=" The estimated drug-drug interaction (DDI) indices (&gt;0" /><sentence text="1) indicated a very strong potential for clinically relevant, rhein perpetrated DDIs mediated by inhibition of hOAT1 (DDI index=5"><entity charOffset="62-66" id="DDI-PubMed.23973525.s13.e0" text="rhein" /></sentence><sentence text="0; 83% inhibition) and/or hOAT3 (DDI index=46; 98% inhibition) transport activity" /><sentence text=" These results suggested that rhein, from herbal medicines and/or prodrug conversion, may significantly impact the dosing, efficacy and toxicity (i"><entity charOffset="30-34" id="DDI-PubMed.23973525.s15.e0" text="rhein" /></sentence><sentence text="e" /><sentence text=", pharmacokinetics and pharmacodynamics) of co-administered hOAT1 and/or hOAT3 drug substrates" /><sentence text="" /></document>